Literature DB >> 17109828

Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease.

Wendy M Brooks1, Patrick J Lynch, Catherine C Ingle, Alexander Hatton, Piers C Emson, Richard L M Faull, Mike P Starkey.   

Abstract

The successfully functioning brain is a heavy user of metabolic energy. Alzheimer's disease, in which cognitive faculties decline, may be due, at least in part, to metabolic insufficiency. Using microarray analysis and quantitative RT-PCR, the expression of mRNA transcripts involved in glucose metabolism was investigated in Alzheimer's diseased post-mortem human hippocampal samples. Of the 51 members of the glycolytic, tricarboxylic acid cycle, oxidative phosphorylation, and associated pathways investigated by qPCR, 15 were confirmed to be statistically significantly (p<0.05) down-regulated in Alzheimer's disease. This finding suggests that reductions in the levels of transcripts encoded by genes that participate in energy metabolism may be involved in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109828     DOI: 10.1016/j.brainres.2006.09.106

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  50 in total

1.  Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.

Authors:  Baiyang Sheng; Xinglong Wang; Bo Su; Hyoung-gon Lee; Gemma Casadesus; George Perry; Xiongwei Zhu
Journal:  J Neurochem       Date:  2011-12-08       Impact factor: 5.372

Review 2.  Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.

Authors:  Puneet Talwar; Juhi Sinha; Sandeep Grover; Chitra Rawat; Suman Kushwaha; Rachna Agarwal; Vibha Taneja; Ritushree Kukreti
Journal:  Mol Neurobiol       Date:  2015-09-09       Impact factor: 5.590

3.  Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.

Authors:  Vladimir Volloch; Bjorn Olsen; Sophia Rits
Journal:  Ann Integr Mol Med       Date:  2020

4.  Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.

Authors:  Vladimir Volloch; Bjorn R Olsen; Sophia Rits
Journal:  Ann Integr Mol Med       Date:  2019-11-20

5.  Rare Variants and Transcriptomics in Alzheimer disease.

Authors:  Crystal Humphries; Martin A Kohli
Journal:  Curr Genet Med Rep       Date:  2014-06-01

Review 6.  Inflammation and programmed cell death in Alzheimer's disease: comparison of the central nervous system and peripheral blood.

Authors:  Beatrice Macchi; Francesca Marino-Merlo; Caterina Frezza; Salvatore Cuzzocrea; Antonio Mastino
Journal:  Mol Neurobiol       Date:  2014-01-21       Impact factor: 5.590

7.  Selective neuronal vulnerability to oxidative stress in the brain.

Authors:  Xinkun Wang; Elias K Michaelis
Journal:  Front Aging Neurosci       Date:  2010-03-30       Impact factor: 5.750

8.  Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase.

Authors:  Mohammad Ali Faghihi; Farzaneh Modarresi; Ahmad M Khalil; Douglas E Wood; Barbara G Sahagan; Todd E Morgan; Caleb E Finch; Georges St Laurent; Paul J Kenny; Claes Wahlestedt
Journal:  Nat Med       Date:  2008-06-29       Impact factor: 53.440

Review 9.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

Review 10.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.